Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn
- 17 July 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 229 (04) , 223-228
Abstract
Aim To investigate whether increased brain natriuretic propeptide (NT-proBNP) levels at 48 to 72 h of life are associated with the development of bronchopulmonary dysplasia (BPD) or death in premature neonates. Methods A retrospective study was performed in neonates born before 32 weeks’ gestation or with birth weight below 1500 grams, in whom NT-proBNP determination and echocardiography were performed at 48 to 72 h of life. Associations between NT-proBNP levels and the combined outcome BPD or death were analyzed using multivariate logistic regression analysis. Results 117 neonates with mean gestational age 27.8±2.1 weeks and birth weight 949.7±267.5 grams were included. Forty (34.2%) had an outcome of BPD or death. The risk of this combined outcome was found to be 3.95-fold higher (OR 3.95; 95% CI 1.1–14.6) in neonates with NT-proBNP levels above 17800 pg/mL. Conclusion Increased NT-proBNP levels may be associated with a significant decrease in BPD-free survival in very immature newborns.Keywords
This publication has 22 references indexed in Scilit:
- Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational studyBMC Pediatrics, 2015
- Managing the patent ductus arteriosus: current treatment optionsArchives of Disease in Childhood - Fetal and Neonatal Edition, 2014
- The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaSeminars in Perinatology, 2013
- Urinary N-Terminal B-Type Natriuretic Peptide Predicts Severe Retinopathy of PrematurityPediatrics, 2011
- Long-term outcomes of bronchopulmonary dysplasiaSeminars in Fetal and Neonatal Medicine, 2009
- N-terminal-Pro-B-Type Natriuretic Peptide in Premature Patent Ductus Arteriosus: A Physiologic Biomarker, But Is It a Clinical Tool?Pediatric Cardiology, 2009
- Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definitionSeminars in Neonatology, 2003
- Disrupted Pulmonary Vasculature and Decreased Vascular Endothelial Growth Factor, Flt-1, and TIE-2 in Human Infants Dying with Bronchopulmonary DysplasiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Neonatal Chronic Lung Disease in Extremely Immature BaboonsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosusThe Journal of Pediatrics, 1979